107 Citations (Scopus)

Abstract

Objective: To investigate the risk of stroke development following a diagnosis of herpes zoster ophthalmicus (HZO). METHODS: Data were retrospectively collected from the Taiwan National Health Insurance Research Database. The study cohort comprised all patients with a diagnosis of HZO (ICD-9-CM code 053.2) in 2003 and 2004 (n = 658). The comparison cohort was comprised of randomly selected patients (3 for every HZO patient, n = 1974) matched with the study group in terms of age and gender. Patients were tracked from their index visits for 1 year. The Kaplan-Meier method was utilized to compute the 1-year stroke-free survival rate. Cox proportional hazard regressions were carried out to compute the adjusted 1-year stroke-free survival rate after adjusting for possible confounding factors. Results: Stroke developed in 8.1% of patients with HZO and 1.7% of patients in the comparison cohort during the 1-year follow-up period. HZO patients had significantly lower 1-year stroke-free survival rates than patients in the comparison cohort. After adjusting for patients' demographic characteristics, selected comorbidities, and medication habits, HZO patients were found to have a 4.52-fold (95% confidence interval 2.45-8.33) higher risk of stroke than the matched comparison cohort. There was no significant difference in the rate of stroke development between patients who had received systemic antiviral treatment and those who had not. Conclusions: Herpes zoster ophthalmicus may represent a marker of increased risk of stroke development during the 1-year follow-up period.

Original languageEnglish
Pages (from-to)792-797
Number of pages6
JournalNeurology
Volume74
Issue number10
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Herpes Zoster Ophthalmicus
Stroke
Population
Survival Rate
National Health Programs
International Classification of Diseases
Taiwan
Habits
Antiviral Agents
Comorbidity

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Herpes zoster ophthalmicus and the risk of stroke : A population-based follow-up study. / Lin, Herng Ching; Chien, Ching Wen; Ho, Jau Der.

In: Neurology, Vol. 74, No. 10, 03.2010, p. 792-797.

Research output: Contribution to journalArticle

@article{58e223a9059c48d49fbb2becb9810bde,
title = "Herpes zoster ophthalmicus and the risk of stroke: A population-based follow-up study",
abstract = "Objective: To investigate the risk of stroke development following a diagnosis of herpes zoster ophthalmicus (HZO). METHODS: Data were retrospectively collected from the Taiwan National Health Insurance Research Database. The study cohort comprised all patients with a diagnosis of HZO (ICD-9-CM code 053.2) in 2003 and 2004 (n = 658). The comparison cohort was comprised of randomly selected patients (3 for every HZO patient, n = 1974) matched with the study group in terms of age and gender. Patients were tracked from their index visits for 1 year. The Kaplan-Meier method was utilized to compute the 1-year stroke-free survival rate. Cox proportional hazard regressions were carried out to compute the adjusted 1-year stroke-free survival rate after adjusting for possible confounding factors. Results: Stroke developed in 8.1{\%} of patients with HZO and 1.7{\%} of patients in the comparison cohort during the 1-year follow-up period. HZO patients had significantly lower 1-year stroke-free survival rates than patients in the comparison cohort. After adjusting for patients' demographic characteristics, selected comorbidities, and medication habits, HZO patients were found to have a 4.52-fold (95{\%} confidence interval 2.45-8.33) higher risk of stroke than the matched comparison cohort. There was no significant difference in the rate of stroke development between patients who had received systemic antiviral treatment and those who had not. Conclusions: Herpes zoster ophthalmicus may represent a marker of increased risk of stroke development during the 1-year follow-up period.",
author = "Lin, {Herng Ching} and Chien, {Ching Wen} and Ho, {Jau Der}",
year = "2010",
month = "3",
doi = "10.1212/WNL.0b013e3181d31e5c",
language = "English",
volume = "74",
pages = "792--797",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Herpes zoster ophthalmicus and the risk of stroke

T2 - A population-based follow-up study

AU - Lin, Herng Ching

AU - Chien, Ching Wen

AU - Ho, Jau Der

PY - 2010/3

Y1 - 2010/3

N2 - Objective: To investigate the risk of stroke development following a diagnosis of herpes zoster ophthalmicus (HZO). METHODS: Data were retrospectively collected from the Taiwan National Health Insurance Research Database. The study cohort comprised all patients with a diagnosis of HZO (ICD-9-CM code 053.2) in 2003 and 2004 (n = 658). The comparison cohort was comprised of randomly selected patients (3 for every HZO patient, n = 1974) matched with the study group in terms of age and gender. Patients were tracked from their index visits for 1 year. The Kaplan-Meier method was utilized to compute the 1-year stroke-free survival rate. Cox proportional hazard regressions were carried out to compute the adjusted 1-year stroke-free survival rate after adjusting for possible confounding factors. Results: Stroke developed in 8.1% of patients with HZO and 1.7% of patients in the comparison cohort during the 1-year follow-up period. HZO patients had significantly lower 1-year stroke-free survival rates than patients in the comparison cohort. After adjusting for patients' demographic characteristics, selected comorbidities, and medication habits, HZO patients were found to have a 4.52-fold (95% confidence interval 2.45-8.33) higher risk of stroke than the matched comparison cohort. There was no significant difference in the rate of stroke development between patients who had received systemic antiviral treatment and those who had not. Conclusions: Herpes zoster ophthalmicus may represent a marker of increased risk of stroke development during the 1-year follow-up period.

AB - Objective: To investigate the risk of stroke development following a diagnosis of herpes zoster ophthalmicus (HZO). METHODS: Data were retrospectively collected from the Taiwan National Health Insurance Research Database. The study cohort comprised all patients with a diagnosis of HZO (ICD-9-CM code 053.2) in 2003 and 2004 (n = 658). The comparison cohort was comprised of randomly selected patients (3 for every HZO patient, n = 1974) matched with the study group in terms of age and gender. Patients were tracked from their index visits for 1 year. The Kaplan-Meier method was utilized to compute the 1-year stroke-free survival rate. Cox proportional hazard regressions were carried out to compute the adjusted 1-year stroke-free survival rate after adjusting for possible confounding factors. Results: Stroke developed in 8.1% of patients with HZO and 1.7% of patients in the comparison cohort during the 1-year follow-up period. HZO patients had significantly lower 1-year stroke-free survival rates than patients in the comparison cohort. After adjusting for patients' demographic characteristics, selected comorbidities, and medication habits, HZO patients were found to have a 4.52-fold (95% confidence interval 2.45-8.33) higher risk of stroke than the matched comparison cohort. There was no significant difference in the rate of stroke development between patients who had received systemic antiviral treatment and those who had not. Conclusions: Herpes zoster ophthalmicus may represent a marker of increased risk of stroke development during the 1-year follow-up period.

UR - http://www.scopus.com/inward/record.url?scp=77949353322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949353322&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3181d31e5c

DO - 10.1212/WNL.0b013e3181d31e5c

M3 - Article

C2 - 20200348

AN - SCOPUS:77949353322

VL - 74

SP - 792

EP - 797

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 10

ER -